Recently Featured

Japan’s MHLW Approves Boehringer’s Jascayd for IPF and PPF

June 10, 2026
Boehringer Ingelheim has secured approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Jascayd (nerandomilast), a significant advancement in the treatment landscape for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). This approval marks a pivotal moment for patients suffering from these debilitating conditions, as Jascayd offers a new therapeutic option aimed…

Microbiotica Reports Positive Results for MB097 in Advanced Melanoma

June 10, 2026
Microbiotica has announced promising data from its clinical trials for MB097, a novel microbiome co-therapy aimed at treating advanced melanoma. The results indicate that MB097 may enhance the efficacy of anti-PD-1 therapies, particularly in patients who have developed resistance to these treatments. This breakthrough suggests a potential shift in the therapeutic landscape for melanoma, where…

U.K. Advocacy Groups Threaten Legal Action Over U.S. Pharma Trade Deal Provisions

June 9, 2026
Two advocacy groups are demanding that the United Kingdom revoke regulations central to a new trade agreement with the U.S., citing concerns that the deal could permit external influences on the cost-effectiveness assessments of medicines. Should the government fail to comply with their demands, the groups are prepared to initiate legal proceedings. The trade agreement,…

Bill Cassidy Loses Senate Primary as Trump-Endorsed Candidates Advance to Runoff

June 9, 2026
Bill Cassidy, a prominent Republican figure in health care policy, has lost his seat in the Louisiana Senate primary, setting the stage for a runoff between state treasurer John Fleming and Rep. Julia Letlow, who has secured the endorsement of former President Trump. Initial election results indicate Letlow leads with over 44% of the vote,…

Ongoing Cases